Jeffrey Indes to Arterial Occlusive Diseases
This is a "connection" page, showing publications Jeffrey Indes has written about Arterial Occlusive Diseases.
Connection Strength
2.189
-
Indes JE, Koleilat I, Hatch AN, Choinski K, Jones DB, Aldailami H, Billett H, Denesopolis JM, Lipsitz E. Early experience with arterial thromboembolic complications in patients with COVID-19. J Vasc Surg. 2021 Feb; 73(2):381-389.e1.
Score: 0.672
-
Indes JE, Pfaff MJ, Farrokhyar F, Brown H, Hashim P, Cheung K, Sosa JA. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther. 2013 Aug; 20(4):443-55.
Score: 0.412
-
Indes JE, Tuggle CT, Mandawat A, Muhs BE, Sosa JA. Effect of physician and hospital experience on patient outcomes for endovascular treatment of aortoiliac occlusive disease. Arch Surg. 2011 Aug; 146(8):966-71.
Score: 0.358
-
Indes JE, Tuggle CT, Mandawat A, Sosa JA. Age-stratified outcomes in elderly patients undergoing open and endovascular procedures for aortoiliac occlusive disease. Surgery. 2010 Aug; 148(2):420-8.
Score: 0.332
-
Indes JE, Shah HJ, Jonker FH, Ohki T, Veith FJ, Lipsitz EC. Subintimal angioplasty is superior to SilverHawk atherectomy for the treatment of occlusive lesions of the lower extremities. J Endovasc Ther. 2010 Apr; 17(2):243-50.
Score: 0.327
-
Gargiulo NJ, O'Connor DJ, Indes JE, Feinberg E, Lipsitz EC, Suggs WD. Is the length of follow-up evaluation in published reports on the treatment of infrainguinal occlusive disease decreasing? Am J Surg. 2011 Aug; 202(2):179-83.
Score: 0.088